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Abstract:    
Treatment of 2,3-di-(4-chlorophenyl) oxirane-2,3-dicarbonitriles(1) with nitrogen nucleophiles, e.g. N2H4, 
NH2OH afforded pyrazole 2, 1.2oxazole 3 derivatives respectively The 3-amino pyrazole-4-one derivatives 2 
can be used as a key starting materials to synthesize some important Schiff base 4 and fused heterocyclic 
compounds e.g. Imidazolo-[4,5-c]pyrazole 5, Pyrazolo[3,4-e]1,2,4-triazine 6, pyrazol[1,2-a] 1,3,5-triazine 7, 8 
and 9. The electromeric effect of the halogen atom in the aryl moieties can be controlled upon the rate of 
reaction and the yield of the product. The structures of synthesized new compounds were characterized by 
spectral data and screened for their antimicrobial activities against various bacteria and fungi strains. The 
heterocyclic compounds 7, 8 and 9 that contained bridgehead nitrogen gave an excellent result.   
Keywords: Oxirane, Pyrazole, Isooxazole, Schiff Base, Imidazole, Triazine.  
Introduction  
2,3-Diaryloxirane-2,3-dicarbonitriles were well-known as important synthetic intermediates [1]. The reported 
synthetic method for 2,3-diaryloxirane-2,3-dicarbonitriles to afford the substituted pyrazole and isoxazole 
moieties should be discussed [2,3]. An important class of compounds in the field of agricultural and medicinal 
chemistry because of their broad-spectrum biological activities [4,5], cancer therapy such as pyrazoles [6]. 
Successful as antifungal agents and when fused imidazole derivatives [7-9] were combined with antibacterial 
agents (vancomycin, ciprofloxacin) that observed antagonistic activity results from the competitive binding of 
the medicine molecules into fungi cells receptors. Also, the imidazolo-oxazole derivatives have been tested 
for antimycobacterial activity via treatment of imidazole derivatives with oxirane and the presence of 
imidazolothiadiazole moieties that be considered as antibacterial agents. 3-phenylamino-(substituted phenyl) 
isoxazolines [10-12] were evaluated for their in vitro antifungal activity and on the proliferative response of 
human mononuclear peripheral blood cells to phytohemagglutinin A (PHA). Schiff bases have remarkable 
property of forming complexes and serve as excellent chelating ligands and have been used [13-20] as 
analytical reagents for the spectrophotometric determination of metal ions. It’s reported [21-25] that the 
behavior of 2,3-diaryloxirane-2,3-dicarbonitriles towards different carbon and nitrogen nucleophiles. 
Results and Discussion 
Chemistry  
The different kinds of electrophilic centre in the 2,3–Diaryloxirane-2,3-dicarbonitriles (1) can able to be 
allowed to react with simply bi-nucleophiles to afford the new heterocyclic compounds, they were depended 
upon the type of nucleophile. The stability of the Schiff bases 4 can be controlled upon the migration of the 
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aryl groups in position 5 in pyrazole moiety, whenever the attacking nucleophiles approached. The reaction of 
2,3–diaryl oxirane-2,3-dicarbonitriles (1) can be allowed to react with simply binucleophiles e.g. hydrazine 
derivatives and hydroxylamine (Scheme 1) to afford an important heterocyclic compounds pyrazole and 
isoxazole derivatives respectively. The reaction of the cyano oxirane 1 with hydrazine hydrate affords the 
pyrazole derivatives 2. The yield of the products reflected the stability of the compounds 2 and how the aryl 
substituents have been saved theirs and occur intramolecular 1,2[H] shift to afford the more stable products. 
But, the formation of the isoxazole derivatives 3 can be proved that the mechanism could be of the bonding 
rearrangement as outlined in figure of intermediate (Scheme 1).  
Fig 1 outline the HOMO and LUMO optimization structure of the Schiff base 4 
 
 
















spectral analysis indicated the presence of carbonyl groups, and the absence of the cyano groups. The 
substituted aryl groups (electrometric effect of chlorine atom that presented in the aryl group) caused increase 
the migratory aptitude of aryl groups and deactivating the enamine group and enhanced the rate of reaction. 
The pyrazole derivatives 2 can be supported chemically when the pyrazole derivatives 2 were submitted to 
react with benzaldehyde in the presence of boiling ethanol afforded the Schiff base 4. The presence of halogen 
atom in Schiff base can be affected upon their reactivity and increased the yield of products. Moreover, DFT 
study can be outlined the electron density sites of the Schiff base and helped the authors to explain the 
reaction course of the Schiff base 4 with different nucleophilic and electrophilic reagents. So, fusion of the 
arylidene 4 with ammonium acetate afford imidazolopyrazole 5 in high yield due to improvement the 
electronic effect of the chlorine atom. Refluxing the arylidene 4 with hydrazine hydrate in boiling ethanol 
afforded the pyrazolo[3,4-e] 1,2,4-triazine derivatives 6 (Scheme 2). The derivatives 5, and 6 were in good 
yield via spontaneous [1,3]H shift to afford the more thermodynamically stable (cisoid form) of the derivatives 
5 and 6. 1,3-Hydrogen shift was energetically more favored to transfer than the aryl group that transfer to 
nitrogen.  It's well-known that the electron-rich rings are good migrating group, so they can be enhancement 
the rate of reaction. 
13C-NMR can be confirmed that the two aryl groups were in a different position and not on the same site, i.e. 
occur migration. Now, let’s take a more detailed look when the Schiff base 4 could be allowed to react with 
urea in boiling ethanol afforded pyrazolotriazine 7. The elemental and spectral data are agreement with the 
structure of the isolated products 7. The simplified 1H-, 13C-NMR of the 4 aryl groups can have helped us to 
form the proposal mechanism to afford pyrazolotriazine derivatives 7. The reaction of the arylidene of 
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pyrazolo[1,2-a]1,3,5-triazine 8a, and 8b respectively. The reaction was formed via the nucleophilic addition of 
N2 of the pyrazole, migration of aryl followed by the ring closure. The driving force to the migration of the aryl 
group was due to afford the more thermodynamic stable aromaticity and intramolecular hydrogen bond in 
addition to steric crowding support to the formation of the product 8a that confirmed by the 1H- and 13C-
NMR spectra inside of the product 8b. The pyrazolo[1,2-c]1,3,4-thiadiazine 9 can be isolated only via the 
reaction of the N2 of pyrazole as nucleophile with carbon disulfide as electrophile and ring migration followed 
by cyclization.   The structure of product 9 can be confirmed by elemental and spectral date.  Pyrazolo[1,2-
a]1,3,5-triazine and the corresponding heterocyclic analogs are valuable intermediates in organic synthesis 
[26] and exhibit a multitude of biological activities [27], widespread distributed in fruits, vegetables, spices, 
tea and soy-based foodstuff, and subject of great interest for their interesting  pharmacological activities [28]. 
They have been recently one of the important biocides and versatile synthons for various chemical 
transformations and highly biologically active with a number of pharmacological and medicinal applications 
[29,30].  
ii- Biological activity  
From the structure-activity relationship (SAR) between aryl vinyl amide and synthetic Schiff base, 4 can be 
indicated the bioisosteric of tyrosine kinase inhibition [31]. From (Table 1), antimicrobial activities of some 
synthetic compounds 2, 3, 4, 5, 6, 7, 8 and 9 have stronger than the natural antibiotics. The authors could be 
explained the bridgehead nitrogen compounds 7, 8a, 8b and 9 that similar to three drugs used to treat erectile 
dysfunction (sildenafil, tadalafil, and vardenafil). There are a wide variety of phosphodiesterases throughout 
the body. These enzymes hydrolyze the cyclic phosphate esters of adenosine monophosphate (cAMP) and 
guanosine monophosphate (cGMP). Although the substrates for this family of enzymes are cAMP and cGMP, 
there are differences in the active sites. They have an important role in maintaining a desired lifestyle: 
treatment of erectile dysfunction caused by various medical conditions. 











2 ++ ++ + ++ 
3 ++ ++ ++ ++ 
4 ++ ++ ++ ++ 
5 + ++ ++ ++ 
6 ++ + + + 
7 + ++ ++ - 
8 ++ ++ ++ + 
9 ++ ++ ++ + 
Chloramphenicol® +++ +++ +++ +++ 
Ampicillin® +++ +++ +++ +++ 
 
The width of the zone of inhibition indicates the potency of antibacterial activity; (−) no antibacterial activity 
(0%–25%); (+) mild activity with the diameter of the zones equal to 0.5–0.8 cm (25dehydroascorbate 40%), 
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(++) moderate activity with the diameter of the zones equal to 1.1–1.2 cm (55%–65%); (+++) marked high 
activity with the diameter of the zones equal to 1.8–2.0 cm (85%–100%).  
Conclusion  
In the present work, the authors can be succeeded to the synthesis of a series of some important Schiff 
bases and novel fused heterocycle derivatives, that be expected to enhance the biological profile many folds 
than their parent nuclei. The electromeric effect of halogen can be controlled in the rate of reaction and 
enhances the yield of synthesized fused heterocycles. Migration of the aryl groups in derivatives of 5, 7, 8, 
and 9 can be confirmed by 1H- and 13C-NMR. The bioisoster of synthetic arylidene of Schiff base to 
arylvinylamide that expects to enhance the biological profile many folds than their parent nuclei. 
Enhancement of the mono- and bi-cyclic compounds contain hetero atom as antimicrobial prove that the 
process of degradation of microbe proceeds via enzymatic inhibition. 
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Experimental 
All melting points are uncorrected and were determined on a Stuart electric melting point apparatus. 
Elemental analyses were carried out at the Microanalytical Centre, National Research Centre, Cairo, Egypt. By 
Elementary Viro El Microanalysis IR spectra (KBr) were recorded on infrared spectrometer FT-IR 400D using 
OMNIC program and are reported frequency of absorption in terms of cm-1 and 1H-NMR spectra recorded on 
a Bruker spectrophotometer at 400 MHz using TMS as internal standard and with residual signals of the 
deuterated solvent δ = 7.26 ppm for CDCl3 and δ 2.51 ppm for DMSO-d6. 13C-NMR spectra were recorded on 
the same spectrometer at 100 MHz and referenced to solvent signals δ = 77 ppm for CDCl3 and δ 39.50 ppm 
for DMSO-d6. DEPT 135 NMR spectroscopy were used where appropriate to aid the assignment of signals in 
the 1H and 13C-NMR spectra. The mass spectra were recorded on Shimadzu GCMS-QP-1000 EX mass 
spectrometer at 70 e.v using the electron ionization technique. Homogeneity of all compounds synthesized 
was checked by TLC. 
General Procedure for the preparation of the compounds 1 is described in the literature[1b].  
The mixture of K4[Fe (CN)6] (0.2 mmol) and aroyl chloride(1 mmol) was heated at 160 oC for 3 h. Then the 
reaction mixture was cooled to room temperature, and triphenylphosphine (0.5 mmol) and triethylamine 
(0.02 mmol) in 10 mL of CH2Cl2 were added. The resulting mixture was stirred at room temperature.  After 
completion of the reaction, monitored by TLC, the resulting mixture was evaporated off the solvent, and the 
residue was subjected to column chromatography to give the pure product. 
General Procedure for the preparation of the compounds 2  
An equimolar mixture of compounds 1 (2.26-3.14 g 0.01 mol) and hydrazine hydrate (0.01 mol) in 50 mL boiling 
ethanol. The reaction mixture was refluxed for 6 h. The solid that separated after cool was filtered off, washed 
by petroleum ether (b.p 40- 60oC), dried and then, crystallized from the proper solvents. 3-Amino-5,5-bis(4-
chlorophenyl)-4-oxo-4,5-dihydropyrazole (2). Yield 74%. m.p.  
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238-240. IR(KBr) ν 3390, 3255(NH), 3055(CHAr), 1706(CO). 1HNMR (DMSO): δ  7.45– 7.7 (m, 8H,ArH), singlet 
at 6.7, 8.3, and 13.2 a acidic 3NH protons which exchanged in D2O, 13C-NMR δ 113.6(2C), 122.1(2CH), 
128.0(2CH), 129.9(CH), 131.3(CH), 132.6(2CH), 135.6(CH), 139.6(CH), 141.5(C), 167.4 (C), 190.2(C)  and Anal. 
Calc. for C15H11N3OCl2: C 56.42, H 3.44, N 13.16, Cl 21.94; found: C 56.47, H 3.39, N 13.12, Cl 21.88. MS:m/z 
319[M+.], 283.5 [M-Cl], 234[diarylmethine]+, 193 [3-amino- 5(4-chlorophenyl) pyrazole] +, 137.5, 70. 
General Procedure for the preparation of the compounds 3  
A mixture of 1 (2.26-3.14g; 0.01 mol) and hydroxyl amine hydrochloride (1.03 g;0.015mol) in boiling pyridine 
(50 mL) and was heated under reflux for 6h. The reaction mixture was allowed to cool, pour into ice/HCl and 
the product was filtered, dried, and were recrystallized from suitable solvent. 
3-Amino-5,5-bis(4-chlorophenyl)-4-oxo-4,5-dihydro-1,2-oxazole (3). Yield 72%. m.p. 238-240. IR(KBr) ν 
3336(NH), 3062 (CHAr), 1726(CO). 1HNMR (DMSO): δ 7.5 – 7.8 (m, 8H, ArH), singlet at 8.1, 12.3 a acidic 2NH 
protons which exchanged in D2O, 13C-NMR δ 113.6(2C), 122.1(2CH), 128.0(2CH), 129.9(CH), 131.3(CH), 
132.6(2CH), 135.6(CH), 139.6(CH), 141.5(C), 167.4 (C), 190.2(C)  and Anal. Calc. for C15H10N2O2Cl2: C 56.25, 
H 3.12, N 8.75, Cl 21.87; found: C 56.27, H 3.15, N 8.72, Cl 21.88. MS:m/z 320[M+.], 292 [M-CO], 284.5 [M-Cl], 
251[diarylketone+.], 234, 140. 
General Procedure for the preparation of the compounds 4  
An equimolar mixture of compounds 2 (2.4-3.3 g; 0.01 mol) and benzaldehyde (0.01 mol) in 50 mL boiling 
ethanol. The reaction mixture was refluxed for 4 h. The solid that separated after cool was filtered off, dried 
and then, crystallized from the proper solvents. 
3-(Benzylidenimino)-5,5-bis(4-chlorophenyl)-4-oxo-4,5-dihydro pyrazole (4). Yield 76%. m.p.252-254. IR (KBr) 
ν 3264(NH), 3058(CHAr), 1729 (CO). 1HNMR (DMSO): δ 6.2(s,1H, CH=), multiplet 7.12 – 7.89 assigned for 
13ArH aromatic protons, singlet at 8.56  acidic NH proton which exchanged in D2O, 13C-NMR δ 110.7(2C), 
112.9(CH), 114.4(CH), 120.8(2CH), 123.2(2CH), 128.1(2CH), 130.8(CH), 131.2(CH), 132.1(2CH), 132.8(2CH),  
134.3(C), 136.8(CH), 138.1(CH), 141.1(C), 168.4(C), 190.0(C) and Anal. Calc. for C22H15N3OCl2: C 64.86, H 
3.68, N 10.31; found: C 64.80, H 3.63, N 10.33. MS: m/z 407[M+.], 354, 236[M+.-(Ph)2O], 260, 235, 145.  
General Procedure for the preparation of the compounds 5  
A mixture of 4 (0.01 mol) and ammonium acetate (2.31 g, 0.03 mol) was heated in an oil bath at 190 0C for 
variable time. The mixture was poured onto water after cooling. The solid that separated after cool was filtered 
off, dried and then, crystallized from the proper solvents. 
3,4-Bis(4-chlorophenyl)-4,5-dihydro-5-phenyl-imidazolo[4,5-c] pyrazole (5). Yield 78%. m.p. 122-124. IR(KBr) ν 
3264, 3197(NH), 3050 (CHAr), 1630 (C=N). 1HNMR (DMSO): δ multiplet 5.3(s,1H, CHAr), 7.22 – 7.89 assigned 
for 13ArH aromatic protons, singlet at 10.1 and 12.9 a acidic 2NH protons which exchanged in D2O, 13C-NMR 
δ 110.7(2C), 112.9(CH), 114.4(CH), 120.8(2CH), 123.2(2CH), 128.1(2CH), 130.8(CH), 131.2(CH), 132.1(2CH), 
132.8(2CH), 134.3(C), 136.8(CH), 138.1(CH), 141.1(C), 167.4(C), 168.0(C) and Anal. Calc. for C22H16N4Cl2: C 
65.02, H 3.94, N 13.79, Cl 17.24; found: C 65.01, H 3.94, N 13.78, Cl 17.23; MS:m/z 370.5[M+.-Cl], 295[M+.- 
PhCl], 281. 
General Procedure for the preparation of the compounds 6  
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An equimolar mixture of compounds 4 (0.01 mol) and hydrazine hydrate (0.01 mol) in 50 mL boiling ethanol. 
The reaction mixture was refluxed for 6 h. The solid that separated after cool was filtered off, washed by 
petroleum ether (b.p 40- 60oC), dried and then, crystallized from the proper solvents. 
3,4-Di(4-chlorophenyl)-6-phenyl- 1,2,3,4-tetrahydropyrazolo[3,4-e]1,2,4-triazine (6). Yield 77%. m.p. 122-124. 
IR(KBr) ν 3484, 3197(NH), 3058 (CHAr), 1602 (C=N). 1HNMR (DMSO): δ 3.93(s,1H, CHAr), 7.09 –7.98 (m, 13ArH 
aromatic protons), broad singlet at 6.7, 8.55 and 12.9 a acidic 3NH protons which exchanged in D2O, protons 
which exchanged in D2O, 13C-NMR δ 110.9(2C), 113.9(CH), 115.4(CH), 117.8(2CH), 120.2(2CH), 126.7(2CH), 
128.8(CH), 130.2(CH), 132.1(2CH), 132.9(2CH), 134.3(C), 136.8(CH), 138.1(CH), 141.1(C), 167.4(C), 168.0(C) 
and Anal. Calc. for C22H17N5Cl2: C 62.70, H 4.03, N 16.62, Cl 16.62; found: C 62.69, H 3.99, N 16.58, Cl 16.60; 
MS:m/z 421[M+.], 385[M+.-Cl], 281, 139.5, 111.5, and Anal. Calc. for C22H17N5Cl2: C 62.70, H 4.03, N 16.62, 
Cl 16.62; found: C 62.69, H 3.99, N 16.58, Cl 16.60; MS:m/z 421[M+.], 385[M+.-Cl], 281, 139.5, 111.5. 
General Procedure for the preparation of the compounds 7  
An equimolar mixture of compound 4 (2.26-3.14g; 0.01 mol) and urea (0.01 mol) in 50 mL boiling ethanol. The 
reaction mixture was refluxed for 4 h. The solid that separated after cool was filtered off, washed by petroleum 
ether (b.p 40- 60oC), dried and then, fraction crystallized from ethanol. 
3,6-Di(4-chlorophenyl)-[1H] pyrazolo [1,2-a]1,3,5-triazine (7). Yield 26%. m.p. 302-304. IR(KBr) ν 3336, 
3290(NH), 3050 (CHAr), 1628 (C=N). 1HNMR (DMSO): δ multiplet at 7.50 – 8.11 assigned for 16ArH aromatic 
protons, singlet 13.2 acidic NH proton which exchanged in D2O, 13C-NMR δ 111.4(2C), 121.3(2CH), 
123.9(2CH), 126.0(2CH), 129.0(2CH), 131.7(2C), 132.0(2C), 133.3(2CH), 133.8(2CH), 137.0(2C), 
137.5(2C),139.4(2CH), 142.1(2CH), 167.42C), 192.1(2C)  and Anal. Calc. for C29H17N3O2Cl4: C 59.89, H 2.92, 
N 7.22, Cl 24.44; found: C 59.87, H 2.92, N 7.24, Cl 24.45. MS:m/z 584[M+.+2], 581[M+.], 263.5, 235, 193 [3-
amino -5(4- chlorophenyl) pyrazole] +. 
General Procedure for the preparation of the compounds 8  
A mixture of 4 (0.01 mol) and acetic anhydride (9.4 mL,0.1mol) and then refluxed on water bath for 2h. The 
excess acetic anhydride was removed by distillation and the separated product was filtered, dried and were 
recrystallized from mix toluene-ethanol.  
5,6-Bis(4-chlorophenyl) pyrazolo[1,2-a]1,3,5-triazine (8a). Yield 74%. m.p. 146-148. IR(KBr) 3050(CHAr), 
2952(CHAli), 1613(C=N). 1HNMR (DMSO): δ 3.5(s, 3H, CH3), 7.22 – 7.75 (m, 8H, ArH). 13C-NMR δ 22.4(CH3), 
109.6(CH), 121.7(CH), 129.7(2CH), 132.5(CH), 133.2(CH), 133.6(CH), 134.6 (CH),138.6(2C), 140.2(C), 141.5(C), 
143.4(C), 144.1(C), 152.6(C), 190.2(C) and Anal. Calc. for C17H11N3OCl2: C 59.47, H 3.20, N 12.24, Cl 20.40; 
found: C 59.46, H 3.19, N 12.22, Cl 20.39. MS: m/z 343 [M+], 328, 285, 121[M+-(2PhCl)], 
5,6-Di(4-chlorophenyl) pyrazolo[1,2-a] 1,3,5-triazine(8b). Yield 70%. m.p. 136-138. IR(KBr) 3061(CHAr), 
2922(CHAli),1630 (C=N), 1HNMR (DMSO): δ 4.24(s,3H, CH3), 6.96 – 7.55(m,6H, ArH). 13C-NMR δ 23.2(CH3), 
129.7(CH),132.5 (CH), 133.6(CH), 134.6(CH), 138.6(CH), 138.9(CH), 141.5(C), 143.4(C), 144.1(C), 189.6(2C), 
192.2(C), and Anal. Calc. for C13H9N3O3: C 61.17, H 3.52, N 16.47; found: C 61.15, H 3.50, N 16.43. MS: m/z 
255 [M+], 240, 197, 188.  
5,6-Di-(4-chlorophenyl)-pyrazolo[1,2-c]1,3,5-thiadiazine (9). Yield 34%. m.p.188-190. IR(KBr) 3435(NH), 
3045(CHAr), 1660 (C=O).1HNMR (DMSO): δ 1.52(s, 3H, CH3), 7.26 – 7.59 (m, 8H, ArH), singlet 14.07 acidic NH 
proton which exchanged in D2O, 13C-NMR δ 21.5(CH3), 108.1(CH), 120.5(CH), 125.8(CH), 128.6(CH), 
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130.7(CH), 131.0(CH), 132.6(CH), 135.6(C), 138.3(C), 137.6(CH), 140.2 (C), 141.5(C), 142.4(C), 146.1(C), 
161.2(C), 190.7(C)  and Anal. Calc. for C17H12N3O2Cl: C 62.67, H 3.68, N 12.90, Cl 10.90; found: C 62.63, H 
3.67, N 12.91, Cl 10.92. MS: m/z 326[M+], 268.5 [M+-MeN=C=O], 213 [M+-PhCl.]. 
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